Adinazolam [Usan] en es it fr

Adinazolam [Usan] Brand names, Adinazolam [Usan] Analogs

Adinazolam [Usan] Brand Names Mixture

  • No information avaliable

Adinazolam [Usan] Chemical_Formula

C19H18ClN5

Adinazolam [Usan] RX_link

No information avaliable

Adinazolam [Usan] fda sheet

Adinazolam [Usan] msds (material safety sheet)

Adinazolam [Usan] Synthesis Reference

No information avaliable

Adinazolam [Usan] Molecular Weight

351.833 g/mol

Adinazolam [Usan] Melting Point

No information avaliable

Adinazolam [Usan] H2O Solubility

No information avaliable

Adinazolam [Usan] State

Solid

Adinazolam [Usan] LogP

4.05

Adinazolam [Usan] Dosage Forms

No information avaliable

Adinazolam [Usan] Indication

For treatment of panic disorder

Adinazolam [Usan] Pharmacology

Adinazolam is a benzodiazepine derivative used to treat anxiety, status epilepticus, and for sedation induction and anterograde amnesia. Adinazolam binds with high affinity to the GABA benzodiazepine receptor complex. Considerable evidence suggest that the central pharmacologic/therapeutic actions of alprazolam are mediated via interaction with this receptor complex.

Adinazolam [Usan] Absorption

No information avaliable

Adinazolam [Usan] side effects and Toxicity

Signs of overdose may include muscle weakness, ataxia, dysarthria and particularly in children paradoxical excitement. In more severe cases diminished reflexes, confusion, and coma may ensue.

Adinazolam [Usan] Patient Information

No information avaliable

Adinazolam [Usan] Organisms Affected

Humans and other mammals